| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 132,3 k € | |||||||||||||||||
| Gross margin | 464,3 k € | +0.9% | 460,1 k € | -0.9% | 464,4 k € | +4.1% | 446,1 k € | +12.3% | 397,1 k € | -7.0% | 427,2 k € | +2.7% | 416,1 k € | -4.5% | 435,7 k € | +13.6% | 383,3 k € | +4.4% | 367,2 k € | +3.4% | 355,0 k € | +9.7% | 323,6 k € | -11.1% | 364,0 k € | +15.9% | 314,0 k € | +22.7% | 255,9 k € | -5.2% | 270,1 k € | +14.9% | 235,0 k € | |
| EBITDA | 3,0 k € | +12.8% | 2,7 k € | -57.5% | 6,3 k € | -47.7% | 12,0 k € | +85.4% | 6,5 k € | -64.4% | 18,2 k € | -27.1% | 24,9 k € | -48.0% | 47,9 k € | +91.7% | 25,0 k € | -33.3% | 37,5 k € | +202.7% | 12,4 k € | +56.6% | 7,9 k € | -64.3% | 22,2 k € | +273.4% | 5,9 k € | +556.1% | -1,3 k € | -102.0% | 64,8 k € | -45.9% | 119,7 k € | |
| Operating profit | 359,6 € | +1833.2% | 18,6 € | -99.3% | 2,6 k € | -70.8% | 8,9 k € | +238.5% | 2,6 k € | -80.9% | 13,7 k € | -32.6% | 20,4 k € | -53.3% | 43,7 k € | +106.8% | 21,1 k € | -38.5% | 34,3 k € | +336.0% | 7,9 k € | +109.8% | 3,8 k € | -79.1% | 17,9 k € | +1288.6% | 1,3 k € | +125.2% | -5,1 k € | -108.1% | 63,0 k € | -46.7% | 118,2 k € | |
| Profit/loss | -0,4 € | +99.9% | -410,6 € | -118.2% | 2,3 k € | -73.7% | 8,6 k € | +263.6% | 2,4 k € | -82.5% | 13,5 k € | -32.5% | 20,0 k € | -53.8% | 43,3 k € | +108.9% | 20,7 k € | -39.3% | 34,2 k € | +324.3% | 8,1 k € | +117.4% | 3,7 k € | -80.2% | 18,7 k € | +877.4% | 1,9 k € | +143.6% | -4,4 k € | -120.0% | 21,9 k € | -81.4% | 118,1 k € | |
| Equity | 181,3 k € | -0.0% | 181,3 k € | -0.2% | 181,7 k € | +1.3% | 179,4 k € | +5.0% | 170,9 k € | +1.4% | 168,5 k € | +8.7% | 155,0 k € | +14.8% | 134,9 k € | +47.3% | 91,6 k € | +29.3% | 70,9 k € | +93.1% | 36,7 k € | +28.1% | 28,6 k € | +14.8% | 24,9 k € | +299.4% | 6,2 k € | -95.1% | 126,3 k € | -30.5% | 181,7 k € | +13.7% | 159,8 k € | |
| Total assets | 430,8 k € | +15.6% | 372,8 k € | -5.7% | 395,2 k € | +10.6% | 357,2 k € | +3.6% | 344,9 k € | -11.0% | 387,7 k € | +24.3% | 312,0 k € | +5.0% | 297,0 k € | -6.8% | 318,7 k € | +10.4% | 288,7 k € | +51.6% | 190,5 k € | -48.4% | 369,0 k € | -6.4% | 394,4 k € | +14.7% | 343,7 k € | -13.9% | 399,0 k € | -17.1% | 481,4 k € | +5.8% | 455,1 k € | |
| Cash | 321,4 k € | +36.7% | 235,1 k € | -14.0% | 273,3 k € | +19.2% | 229,3 k € | -14.0% | 266,7 k € | -9.8% | 295,6 k € | +33.6% | 221,3 k € | -5.3% | 233,7 k € | +39.6% | 167,4 k € | -9.2% | 184,3 k € | +60.5% | 114,8 k € | -51.5% | 236,8 k € | -4.5% | 247,9 k € | +5.0% | 236,0 k € | +10.1% | 214,3 k € | -9.3% | 236,3 k € | +56.8% | 150,7 k € | |
| Debts | 106,5 k € | +55.8% | 68,4 k € | -26.4% | 92,9 k € | +2.9% | 90,3 k € | +4.2% | 86,6 k € | -34.3% | 131,8 k € | +101.0% | 65,6 k € | -11.0% | 73,7 k € | +1.3% | 72,8 k € | +14.7% | 63,5 k € | +51.0% | 42,0 k € | +176.1% | 15,2 k € | +20.2% | 12,7 k € | +24.7% | 10,2 k € | +34.6% | 7,5 k € | +4.5% | 7,2 k € | -85.9% | 51,4 k € | |
| Staff | — | — | 6,9 | 7,8 | 7 | 7,7 | 7 | 7,1 | 7,3 | 6,4 | 5,9 | 6,1 | 7,9 | 7,4 | 6,8 | 5,9 | 5 | |||||||||||||||||
Non-profit organization · Woluwe-Saint-Lambert · incorporated on 14/09/2007
Non-profit organization loss-making in the latest fiscal year. Cash position rising (+36.7%).
Solid counterparty for a standard engagement.
centre d'epidemiologie perinatale is a Non-profit organization incorporated in 2007. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Woluwe-Saint-Lambert.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette